Pfizer in talks to merge off-patent drugs business with Mylan: source
Go back to Pfizer in talks to merge off-patent drugs business with Mylan: source| Mylan Inc. (NASDAQ: MYL) | Delayed: 15.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.86 | 52 Week High | $55.51 | |||
| Open | $10.56 | 52 Week Low | $33.60 | |||
| Day High | $15.86 | P/E | 10.43 | |||
| Day Low | $15.86 | EPS | $1.52 | |||
| Volume | 45,581 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.79 -0.66 (2.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.45 | 52 Week High | $37.39 | |||
| Open | $28.01 | 52 Week Low | $28.25 | |||
| Day High | $28.15 | P/E | 16.84 | |||
| Day Low | $27.72 | EPS | $1.65 | |||
| Volume | 31,720,716 | |||||
